138 related articles for article (PubMed ID: 18181252)
1. Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography.
Anderer P; Saletu B; Wolzt M; Culic S; Assandri A; Nannipieri F; Rosini S; Saletu-Zyhlarz GM
Hum Psychopharmacol; 2008 Apr; 23(3):243-54. PubMed ID: 18181252
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
[TBL] [Abstract][Full Text] [Related]
4. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Saletu B; Zeitlhofer J
Sleep Med; 2009 Sep; 10(8):850-8. PubMed ID: 19342295
[TBL] [Abstract][Full Text] [Related]
5. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography).
Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():121-37. PubMed ID: 12575494
[TBL] [Abstract][Full Text] [Related]
6. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
Anderer P; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Pascual-Marqui RD
Neuropsychobiology; 2004; 49(3):134-53. PubMed ID: 15034229
[TBL] [Abstract][Full Text] [Related]
7. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
[TBL] [Abstract][Full Text] [Related]
9. Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials.
Anderer P; Saletu B; Gruber D; Linzmayer L; Semlitsch HV; Saletu-Zyhlarz G; Brandstätter N; Metka M; Huber J
Maturitas; 2005 Jul; 51(3):254-69. PubMed ID: 15978969
[TBL] [Abstract][Full Text] [Related]
10. Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugs.
Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():85-91. PubMed ID: 12575474
[TBL] [Abstract][Full Text] [Related]
11. Analgesic potency of a new anticonvulsant drug versus acetylsalicylic acid via laser somatosensory evoked potentials. Randomized placebo-controlled double-blind (5-way) crossover study.
Schaffler K; Wauschkuhn CH; Gierend M
Arzneimittelforschung; 1991 Apr; 41(4):427-35. PubMed ID: 1859518
[TBL] [Abstract][Full Text] [Related]
12. The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures.
Papadopoulos A; Rich A; Nutt DJ; Bailey JE
J Psychopharmacol; 2010 May; 24(5):649-56. PubMed ID: 18832434
[TBL] [Abstract][Full Text] [Related]
13. Arachidonic acid supplementation decreases P300 latency and increases P300 amplitude of event-related potentials in healthy elderly men.
Ishikura Y; Ikeda G; Akimoto K; Hata M; Kusumoto A; Kidokoro A; Kontani M; Kawashima H; Kiso Y; Koga Y
Neuropsychobiology; 2009; 60(2):73-9. PubMed ID: 19752581
[TBL] [Abstract][Full Text] [Related]
14. Effects of a small dose of triazolam on P300.
Hayakawa T; Uchiyama M; Urata J; Enomoto T; Okubo J; Okawa M
Psychiatry Clin Neurosci; 1999 Apr; 53(2):185-7. PubMed ID: 10459684
[TBL] [Abstract][Full Text] [Related]
15. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.
Saletu B; Grünberger J; Anderer P; Linzmayer L
Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257
[TBL] [Abstract][Full Text] [Related]
16. The effect of the new antiepileptic drug rufinamide on cognitive functions.
Aldenkamp AP; Alpherts WC
Epilepsia; 2006 Jul; 47(7):1153-9. PubMed ID: 16886978
[TBL] [Abstract][Full Text] [Related]
17. Effects of cortisol on the laterality of the neural correlates of episodic memory.
Alhaj HA; Massey AE; McAllister-Williams RH
J Psychiatr Res; 2008 Oct; 42(12):971-81. PubMed ID: 18187154
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
[TBL] [Abstract][Full Text] [Related]
19. Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study.
Collie A; Darekar A; Weissgerber G; Toh MK; Snyder PJ; Maruff P; Huggins JP
Contemp Clin Trials; 2007 Jul; 28(4):391-400. PubMed ID: 17267292
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
